Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Jakesz

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Anti-Cancer Drugs|April 6, 2001
Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patientsG J Locker, C Wenzel, M Schmidinger, et al.
World Journal of Surgery|September 1, 1995
Male breast cancer: Austrian experienceM Stierer, H Rosen, W Weitensfelder, et al.
The New England Journal of Medicine|July 23, 1992
Cutaneous reactions to GM-CSF in inflammatory breast cancerG G Steger, G Locker, H Rainer, et al.
Oncology|March 1, 1995
New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancerG J Locker, R M Mader, J Braun, et al.
British Journal of Clinical Pharmacology|March 1, 1994
Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancerR M Mader, G G Steger, B Rizovski, et al.
Breast Cancer Research and Treatment|November 5, 1998
It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patientsT Gruenberger, M Gorlitzer, T Soliman, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year resultsR Jakesz, G Reiner, M Schemper, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
HER-2 oncogene amplification and overall survival of breast carcinoma patientsF Kury, G Sliutz, M Schemper, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administrationG G Steger, R M Mader, M P Djavanmard, et al.
Oncogene|January 1, 1989
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancerR Zeillinger, F Kury, K Czerwenka, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Anti-Cancer Drugs|April 6, 2001
Unexpected severe myelotoxicity of gemcitabine in pretreated breast cancer patientsG J Locker, C Wenzel, M Schmidinger, et al.
World Journal of Surgery|September 1, 1995
Male breast cancer: Austrian experienceM Stierer, H Rosen, W Weitensfelder, et al.
The New England Journal of Medicine|July 23, 1992
Cutaneous reactions to GM-CSF in inflammatory breast cancerG G Steger, G Locker, H Rainer, et al.
Oncology|March 1, 1995
New mucin-like cancer-associated antigens (CA M 26, CA M 29 and CA 549) and a new proliferation marker (TPS) in patients with primary or advanced breast cancerG J Locker, R M Mader, J Braun, et al.
British Journal of Clinical Pharmacology|March 1, 1994
Pharmacokinetics of rac-leucovorin vs [S]-leucovorin in patients with advanced gastrointestinal cancerR M Mader, G G Steger, B Rizovski, et al.
Breast Cancer Research and Treatment|November 5, 1998
It is possible to omit postoperative irradiation in a highly selected group of elderly breast cancer patientsT Gruenberger, M Gorlitzer, T Soliman, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|January 1, 1989
Significant survival benefit of node-negative breast cancer patients treated with adjuvant chemotherapy: seven-year resultsR Jakesz, G Reiner, M Schemper, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
HER-2 oncogene amplification and overall survival of breast carcinoma patientsF Kury, G Sliutz, M Schemper, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Double modulation of 5-fluorouracil by high-dose leucovorin and interferon alpha 2b in advanced colorectal cancer: a phase I and a phase II study of weekly administrationG G Steger, R M Mader, M P Djavanmard, et al.
Oncogene|January 1, 1989
HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancerR Zeillinger, F Kury, K Czerwenka, et al.
Pageof 19